Global Nuclear Drug for Therapeutic Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
LPI (LP Information)' newest research report, the “Nuclear Drug for Therapeutic Industry Forecast” looks at past sales and reviews total world Nuclear Drug for Therapeutic sales in 2022, providing a comprehensive analysis by region and market sector of projected Nuclear Drug for Therapeutic sales for 2023 through 2029. With Nuclear Drug for Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Drug for Therapeutic industry.
This Insight Report provides a comprehensive analysis of the global Nuclear Drug for Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Drug for Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Drug for Therapeutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Drug for Therapeutic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Drug for Therapeutic.
The global Nuclear Drug for Therapeutic market size is projected to grow from US$ 1634.7 million in 2022 to US$ 2085 million in 2029; it is expected to grow at a CAGR of 3.5% from 2023 to 2029.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 46%, followed by Europe and Asia-Pac
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Drug for Therapeutic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
LPI (LP Information)' newest research report, the “Nuclear Drug for Therapeutic Industry Forecast” looks at past sales and reviews total world Nuclear Drug for Therapeutic sales in 2022, providing a comprehensive analysis by region and market sector of projected Nuclear Drug for Therapeutic sales for 2023 through 2029. With Nuclear Drug for Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Drug for Therapeutic industry.
This Insight Report provides a comprehensive analysis of the global Nuclear Drug for Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Drug for Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Drug for Therapeutic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Drug for Therapeutic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Drug for Therapeutic.
The global Nuclear Drug for Therapeutic market size is projected to grow from US$ 1634.7 million in 2022 to US$ 2085 million in 2029; it is expected to grow at a CAGR of 3.5% from 2023 to 2029.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 46%, followed by Europe and Asia-Pac
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Drug for Therapeutic market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Radium-223
- Lutetium-177
- Iodine-131
- Other
- Thyroid
- Bone Metastasis
- Lymphoma
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Novartis
- China Isotope & Radiation
- Dongcheng
- Q BioMed
- Curium Pharmaceuticals
- Jubilant DraxImage
- Lantheus
- Spectrum Pharmaceuticals
- Progenics Pharmaceuticals
- International Isotopes
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Drug for Therapeutic Market Size 2018-2029
2.1.2 Nuclear Drug for Therapeutic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nuclear Drug for Therapeutic Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Nuclear Drug for Therapeutic Market Size by Type
2.3.1 Nuclear Drug for Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
2.4 Nuclear Drug for Therapeutic Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Nuclear Drug for Therapeutic Market Size by Application
2.5.1 Nuclear Drug for Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
3 NUCLEAR DRUG FOR THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Nuclear Drug for Therapeutic Market Size Market Share by Players
3.1.1 Global Nuclear Drug for Therapeutic Revenue by Players (2018-2023)
3.1.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Nuclear Drug for Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEAR DRUG FOR THERAPEUTIC BY REGIONS
4.1 Nuclear Drug for Therapeutic Market Size by Regions (2018-2023)
4.2 Americas Nuclear Drug for Therapeutic Market Size Growth (2018-2023)
4.3 APAC Nuclear Drug for Therapeutic Market Size Growth (2018-2023)
4.4 Europe Nuclear Drug for Therapeutic Market Size Growth (2018-2023)
4.5 Middle East & Africa Nuclear Drug for Therapeutic Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Nuclear Drug for Therapeutic Market Size by Country (2018-2023)
5.2 Americas Nuclear Drug for Therapeutic Market Size by Type (2018-2023)
5.3 Americas Nuclear Drug for Therapeutic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Drug for Therapeutic Market Size by Region (2018-2023)
6.2 APAC Nuclear Drug for Therapeutic Market Size by Type (2018-2023)
6.3 APAC Nuclear Drug for Therapeutic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nuclear Drug for Therapeutic by Country (2018-2023)
7.2 Europe Nuclear Drug for Therapeutic Market Size by Type (2018-2023)
7.3 Europe Nuclear Drug for Therapeutic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Drug for Therapeutic by Region (2018-2023)
8.2 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2018-2023)
8.3 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEAR DRUG FOR THERAPEUTIC MARKET FORECAST
10.1 Global Nuclear Drug for Therapeutic Forecast by Regions (2024-2029)
10.1.1 Global Nuclear Drug for Therapeutic Forecast by Regions (2024-2029)
10.1.2 Americas Nuclear Drug for Therapeutic Forecast
10.1.3 APAC Nuclear Drug for Therapeutic Forecast
10.1.4 Europe Nuclear Drug for Therapeutic Forecast
10.1.5 Middle East & Africa Nuclear Drug for Therapeutic Forecast
10.2 Americas Nuclear Drug for Therapeutic Forecast by Country (2024-2029)
10.2.1 United States Nuclear Drug for Therapeutic Market Forecast
10.2.2 Canada Nuclear Drug for Therapeutic Market Forecast
10.2.3 Mexico Nuclear Drug for Therapeutic Market Forecast
10.2.4 Brazil Nuclear Drug for Therapeutic Market Forecast
10.3 APAC Nuclear Drug for Therapeutic Forecast by Region (2024-2029)
10.3.1 China Nuclear Drug for Therapeutic Market Forecast
10.3.2 Japan Nuclear Drug for Therapeutic Market Forecast
10.3.3 Korea Nuclear Drug for Therapeutic Market Forecast
10.3.4 Southeast Asia Nuclear Drug for Therapeutic Market Forecast
10.3.5 India Nuclear Drug for Therapeutic Market Forecast
10.3.6 Australia Nuclear Drug for Therapeutic Market Forecast
10.4 Europe Nuclear Drug for Therapeutic Forecast by Country (2024-2029)
10.4.1 Germany Nuclear Drug for Therapeutic Market Forecast
10.4.2 France Nuclear Drug for Therapeutic Market Forecast
10.4.3 UK Nuclear Drug for Therapeutic Market Forecast
10.4.4 Italy Nuclear Drug for Therapeutic Market Forecast
10.4.5 Russia Nuclear Drug for Therapeutic Market Forecast
10.5 Middle East & Africa Nuclear Drug for Therapeutic Forecast by Region (2024-2029)
10.5.1 Egypt Nuclear Drug for Therapeutic Market Forecast
10.5.2 South Africa Nuclear Drug for Therapeutic Market Forecast
10.5.3 Israel Nuclear Drug for Therapeutic Market Forecast
10.5.4 Turkey Nuclear Drug for Therapeutic Market Forecast
10.5.5 GCC Countries Nuclear Drug for Therapeutic Market Forecast
10.6 Global Nuclear Drug for Therapeutic Forecast by Type (2024-2029)
10.7 Global Nuclear Drug for Therapeutic Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Nuclear Drug for Therapeutic Product Offered
11.1.3 Bayer Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Nuclear Drug for Therapeutic Product Offered
11.2.3 Novartis Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Information
11.3.2 China Isotope & Radiation Nuclear Drug for Therapeutic Product Offered
11.3.3 China Isotope & Radiation Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 China Isotope & Radiation Main Business Overview
11.3.5 China Isotope & Radiation Latest Developments
11.4 Dongcheng
11.4.1 Dongcheng Company Information
11.4.2 Dongcheng Nuclear Drug for Therapeutic Product Offered
11.4.3 Dongcheng Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Dongcheng Main Business Overview
11.4.5 Dongcheng Latest Developments
11.5 Q BioMed
11.5.1 Q BioMed Company Information
11.5.2 Q BioMed Nuclear Drug for Therapeutic Product Offered
11.5.3 Q BioMed Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Q BioMed Main Business Overview
11.5.5 Q BioMed Latest Developments
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Information
11.6.2 Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
11.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Curium Pharmaceuticals Main Business Overview
11.6.5 Curium Pharmaceuticals Latest Developments
11.7 Jubilant DraxImage
11.7.1 Jubilant DraxImage Company Information
11.7.2 Jubilant DraxImage Nuclear Drug for Therapeutic Product Offered
11.7.3 Jubilant DraxImage Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Jubilant DraxImage Main Business Overview
11.7.5 Jubilant DraxImage Latest Developments
11.8 Lantheus
11.8.1 Lantheus Company Information
11.8.2 Lantheus Nuclear Drug for Therapeutic Product Offered
11.8.3 Lantheus Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Lantheus Main Business Overview
11.8.5 Lantheus Latest Developments
11.9 Spectrum Pharmaceuticals
11.9.1 Spectrum Pharmaceuticals Company Information
11.9.2 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
11.9.3 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Spectrum Pharmaceuticals Main Business Overview
11.9.5 Spectrum Pharmaceuticals Latest Developments
11.10 Progenics Pharmaceuticals
11.10.1 Progenics Pharmaceuticals Company Information
11.10.2 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
11.10.3 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Progenics Pharmaceuticals Main Business Overview
11.10.5 Progenics Pharmaceuticals Latest Developments
11.11 International Isotopes
11.11.1 International Isotopes Company Information
11.11.2 International Isotopes Nuclear Drug for Therapeutic Product Offered
11.11.3 International Isotopes Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 International Isotopes Main Business Overview
11.11.5 International Isotopes Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nuclear Drug for Therapeutic Market Size 2018-2029
2.1.2 Nuclear Drug for Therapeutic Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nuclear Drug for Therapeutic Segment by Type
2.2.1 Radium-223
2.2.2 Lutetium-177
2.2.3 Iodine-131
2.2.4 Other
2.3 Nuclear Drug for Therapeutic Market Size by Type
2.3.1 Nuclear Drug for Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
2.4 Nuclear Drug for Therapeutic Segment by Application
2.4.1 Thyroid
2.4.2 Bone Metastasis
2.4.3 Lymphoma
2.4.4 Other
2.5 Nuclear Drug for Therapeutic Market Size by Application
2.5.1 Nuclear Drug for Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
3 NUCLEAR DRUG FOR THERAPEUTIC MARKET SIZE BY PLAYER
3.1 Nuclear Drug for Therapeutic Market Size Market Share by Players
3.1.1 Global Nuclear Drug for Therapeutic Revenue by Players (2018-2023)
3.1.2 Global Nuclear Drug for Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Nuclear Drug for Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEAR DRUG FOR THERAPEUTIC BY REGIONS
4.1 Nuclear Drug for Therapeutic Market Size by Regions (2018-2023)
4.2 Americas Nuclear Drug for Therapeutic Market Size Growth (2018-2023)
4.3 APAC Nuclear Drug for Therapeutic Market Size Growth (2018-2023)
4.4 Europe Nuclear Drug for Therapeutic Market Size Growth (2018-2023)
4.5 Middle East & Africa Nuclear Drug for Therapeutic Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Nuclear Drug for Therapeutic Market Size by Country (2018-2023)
5.2 Americas Nuclear Drug for Therapeutic Market Size by Type (2018-2023)
5.3 Americas Nuclear Drug for Therapeutic Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Drug for Therapeutic Market Size by Region (2018-2023)
6.2 APAC Nuclear Drug for Therapeutic Market Size by Type (2018-2023)
6.3 APAC Nuclear Drug for Therapeutic Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nuclear Drug for Therapeutic by Country (2018-2023)
7.2 Europe Nuclear Drug for Therapeutic Market Size by Type (2018-2023)
7.3 Europe Nuclear Drug for Therapeutic Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nuclear Drug for Therapeutic by Region (2018-2023)
8.2 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2018-2023)
8.3 Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEAR DRUG FOR THERAPEUTIC MARKET FORECAST
10.1 Global Nuclear Drug for Therapeutic Forecast by Regions (2024-2029)
10.1.1 Global Nuclear Drug for Therapeutic Forecast by Regions (2024-2029)
10.1.2 Americas Nuclear Drug for Therapeutic Forecast
10.1.3 APAC Nuclear Drug for Therapeutic Forecast
10.1.4 Europe Nuclear Drug for Therapeutic Forecast
10.1.5 Middle East & Africa Nuclear Drug for Therapeutic Forecast
10.2 Americas Nuclear Drug for Therapeutic Forecast by Country (2024-2029)
10.2.1 United States Nuclear Drug for Therapeutic Market Forecast
10.2.2 Canada Nuclear Drug for Therapeutic Market Forecast
10.2.3 Mexico Nuclear Drug for Therapeutic Market Forecast
10.2.4 Brazil Nuclear Drug for Therapeutic Market Forecast
10.3 APAC Nuclear Drug for Therapeutic Forecast by Region (2024-2029)
10.3.1 China Nuclear Drug for Therapeutic Market Forecast
10.3.2 Japan Nuclear Drug for Therapeutic Market Forecast
10.3.3 Korea Nuclear Drug for Therapeutic Market Forecast
10.3.4 Southeast Asia Nuclear Drug for Therapeutic Market Forecast
10.3.5 India Nuclear Drug for Therapeutic Market Forecast
10.3.6 Australia Nuclear Drug for Therapeutic Market Forecast
10.4 Europe Nuclear Drug for Therapeutic Forecast by Country (2024-2029)
10.4.1 Germany Nuclear Drug for Therapeutic Market Forecast
10.4.2 France Nuclear Drug for Therapeutic Market Forecast
10.4.3 UK Nuclear Drug for Therapeutic Market Forecast
10.4.4 Italy Nuclear Drug for Therapeutic Market Forecast
10.4.5 Russia Nuclear Drug for Therapeutic Market Forecast
10.5 Middle East & Africa Nuclear Drug for Therapeutic Forecast by Region (2024-2029)
10.5.1 Egypt Nuclear Drug for Therapeutic Market Forecast
10.5.2 South Africa Nuclear Drug for Therapeutic Market Forecast
10.5.3 Israel Nuclear Drug for Therapeutic Market Forecast
10.5.4 Turkey Nuclear Drug for Therapeutic Market Forecast
10.5.5 GCC Countries Nuclear Drug for Therapeutic Market Forecast
10.6 Global Nuclear Drug for Therapeutic Forecast by Type (2024-2029)
10.7 Global Nuclear Drug for Therapeutic Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Nuclear Drug for Therapeutic Product Offered
11.1.3 Bayer Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Nuclear Drug for Therapeutic Product Offered
11.2.3 Novartis Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 China Isotope & Radiation
11.3.1 China Isotope & Radiation Company Information
11.3.2 China Isotope & Radiation Nuclear Drug for Therapeutic Product Offered
11.3.3 China Isotope & Radiation Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 China Isotope & Radiation Main Business Overview
11.3.5 China Isotope & Radiation Latest Developments
11.4 Dongcheng
11.4.1 Dongcheng Company Information
11.4.2 Dongcheng Nuclear Drug for Therapeutic Product Offered
11.4.3 Dongcheng Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Dongcheng Main Business Overview
11.4.5 Dongcheng Latest Developments
11.5 Q BioMed
11.5.1 Q BioMed Company Information
11.5.2 Q BioMed Nuclear Drug for Therapeutic Product Offered
11.5.3 Q BioMed Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Q BioMed Main Business Overview
11.5.5 Q BioMed Latest Developments
11.6 Curium Pharmaceuticals
11.6.1 Curium Pharmaceuticals Company Information
11.6.2 Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
11.6.3 Curium Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Curium Pharmaceuticals Main Business Overview
11.6.5 Curium Pharmaceuticals Latest Developments
11.7 Jubilant DraxImage
11.7.1 Jubilant DraxImage Company Information
11.7.2 Jubilant DraxImage Nuclear Drug for Therapeutic Product Offered
11.7.3 Jubilant DraxImage Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Jubilant DraxImage Main Business Overview
11.7.5 Jubilant DraxImage Latest Developments
11.8 Lantheus
11.8.1 Lantheus Company Information
11.8.2 Lantheus Nuclear Drug for Therapeutic Product Offered
11.8.3 Lantheus Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Lantheus Main Business Overview
11.8.5 Lantheus Latest Developments
11.9 Spectrum Pharmaceuticals
11.9.1 Spectrum Pharmaceuticals Company Information
11.9.2 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
11.9.3 Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Spectrum Pharmaceuticals Main Business Overview
11.9.5 Spectrum Pharmaceuticals Latest Developments
11.10 Progenics Pharmaceuticals
11.10.1 Progenics Pharmaceuticals Company Information
11.10.2 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
11.10.3 Progenics Pharmaceuticals Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Progenics Pharmaceuticals Main Business Overview
11.10.5 Progenics Pharmaceuticals Latest Developments
11.11 International Isotopes
11.11.1 International Isotopes Company Information
11.11.2 International Isotopes Nuclear Drug for Therapeutic Product Offered
11.11.3 International Isotopes Nuclear Drug for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 International Isotopes Main Business Overview
11.11.5 International Isotopes Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nuclear Drug for Therapeutic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Radium-223
Table 3. Major Players of Lutetium-177
Table 4. Major Players of Iodine-131
Table 5. Major Players of Other
Table 6. Nuclear Drug for Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Nuclear Drug for Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Table 9. Nuclear Drug for Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Nuclear Drug for Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Table 12. Global Nuclear Drug for Therapeutic Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Nuclear Drug for Therapeutic Revenue Market Share by Player (2018-2023)
Table 14. Nuclear Drug for Therapeutic Key Players Head office and Products Offered
Table 15. Nuclear Drug for Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Nuclear Drug for Therapeutic Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Nuclear Drug for Therapeutic Market Size Market Share by Regions (2018-2023)
Table 20. Global Nuclear Drug for Therapeutic Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Nuclear Drug for Therapeutic Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Nuclear Drug for Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Nuclear Drug for Therapeutic Market Size Market Share by Country (2018-2023)
Table 24. Americas Nuclear Drug for Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Table 26. Americas Nuclear Drug for Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Table 28. APAC Nuclear Drug for Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Nuclear Drug for Therapeutic Market Size Market Share by Region (2018-2023)
Table 30. APAC Nuclear Drug for Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Table 32. APAC Nuclear Drug for Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Table 34. Europe Nuclear Drug for Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Nuclear Drug for Therapeutic Market Size Market Share by Country (2018-2023)
Table 36. Europe Nuclear Drug for Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Table 38. Europe Nuclear Drug for Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Nuclear Drug for Therapeutic
Table 47. Key Market Challenges & Risks of Nuclear Drug for Therapeutic
Table 48. Key Industry Trends of Nuclear Drug for Therapeutic
Table 49. Global Nuclear Drug for Therapeutic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Nuclear Drug for Therapeutic Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Nuclear Drug for Therapeutic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Nuclear Drug for Therapeutic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Bayer Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 54. Bayer Nuclear Drug for Therapeutic Product Offered
Table 55. Bayer Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Bayer Main Business
Table 57. Bayer Latest Developments
Table 58. Novartis Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 59. Novartis Nuclear Drug for Therapeutic Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Novartis Latest Developments
Table 63. China Isotope & Radiation Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 64. China Isotope & Radiation Nuclear Drug for Therapeutic Product Offered
Table 65. China Isotope & Radiation Main Business
Table 66. China Isotope & Radiation Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. China Isotope & Radiation Latest Developments
Table 68. Dongcheng Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 69. Dongcheng Nuclear Drug for Therapeutic Product Offered
Table 70. Dongcheng Main Business
Table 71. Dongcheng Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Dongcheng Latest Developments
Table 73. Q BioMed Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 74. Q BioMed Nuclear Drug for Therapeutic Product Offered
Table 75. Q BioMed Main Business
Table 76. Q BioMed Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Q BioMed Latest Developments
Table 78. Curium Pharmaceuticals Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 79. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
Table 80. Curium Pharmaceuticals Main Business
Table 81. Curium Pharmaceuticals Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Curium Pharmaceuticals Latest Developments
Table 83. Jubilant DraxImage Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 84. Jubilant DraxImage Nuclear Drug for Therapeutic Product Offered
Table 85. Jubilant DraxImage Main Business
Table 86. Jubilant DraxImage Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Jubilant DraxImage Latest Developments
Table 88. Lantheus Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 89. Lantheus Nuclear Drug for Therapeutic Product Offered
Table 90. Lantheus Main Business
Table 91. Lantheus Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Lantheus Latest Developments
Table 93. Spectrum Pharmaceuticals Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 94. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
Table 95. Spectrum Pharmaceuticals Main Business
Table 96. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Spectrum Pharmaceuticals Latest Developments
Table 98. Progenics Pharmaceuticals Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 99. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
Table 100. Progenics Pharmaceuticals Main Business
Table 101. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Progenics Pharmaceuticals Latest Developments
Table 103. International Isotopes Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 104. International Isotopes Nuclear Drug for Therapeutic Product Offered
Table 105. International Isotopes Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. International Isotopes Main Business
Table 107. International Isotopes Latest Developments
Table 1. Nuclear Drug for Therapeutic Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Radium-223
Table 3. Major Players of Lutetium-177
Table 4. Major Players of Iodine-131
Table 5. Major Players of Other
Table 6. Nuclear Drug for Therapeutic Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global Nuclear Drug for Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Table 9. Nuclear Drug for Therapeutic Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Nuclear Drug for Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Table 12. Global Nuclear Drug for Therapeutic Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global Nuclear Drug for Therapeutic Revenue Market Share by Player (2018-2023)
Table 14. Nuclear Drug for Therapeutic Key Players Head office and Products Offered
Table 15. Nuclear Drug for Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Nuclear Drug for Therapeutic Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global Nuclear Drug for Therapeutic Market Size Market Share by Regions (2018-2023)
Table 20. Global Nuclear Drug for Therapeutic Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global Nuclear Drug for Therapeutic Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas Nuclear Drug for Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas Nuclear Drug for Therapeutic Market Size Market Share by Country (2018-2023)
Table 24. Americas Nuclear Drug for Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Table 26. Americas Nuclear Drug for Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Table 28. APAC Nuclear Drug for Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC Nuclear Drug for Therapeutic Market Size Market Share by Region (2018-2023)
Table 30. APAC Nuclear Drug for Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Table 32. APAC Nuclear Drug for Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Table 34. Europe Nuclear Drug for Therapeutic Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe Nuclear Drug for Therapeutic Market Size Market Share by Country (2018-2023)
Table 36. Europe Nuclear Drug for Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Table 38. Europe Nuclear Drug for Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa Nuclear Drug for Therapeutic Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of Nuclear Drug for Therapeutic
Table 47. Key Market Challenges & Risks of Nuclear Drug for Therapeutic
Table 48. Key Industry Trends of Nuclear Drug for Therapeutic
Table 49. Global Nuclear Drug for Therapeutic Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global Nuclear Drug for Therapeutic Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global Nuclear Drug for Therapeutic Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global Nuclear Drug for Therapeutic Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Bayer Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 54. Bayer Nuclear Drug for Therapeutic Product Offered
Table 55. Bayer Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Bayer Main Business
Table 57. Bayer Latest Developments
Table 58. Novartis Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 59. Novartis Nuclear Drug for Therapeutic Product Offered
Table 60. Novartis Main Business
Table 61. Novartis Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Novartis Latest Developments
Table 63. China Isotope & Radiation Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 64. China Isotope & Radiation Nuclear Drug for Therapeutic Product Offered
Table 65. China Isotope & Radiation Main Business
Table 66. China Isotope & Radiation Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. China Isotope & Radiation Latest Developments
Table 68. Dongcheng Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 69. Dongcheng Nuclear Drug for Therapeutic Product Offered
Table 70. Dongcheng Main Business
Table 71. Dongcheng Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Dongcheng Latest Developments
Table 73. Q BioMed Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 74. Q BioMed Nuclear Drug for Therapeutic Product Offered
Table 75. Q BioMed Main Business
Table 76. Q BioMed Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. Q BioMed Latest Developments
Table 78. Curium Pharmaceuticals Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 79. Curium Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
Table 80. Curium Pharmaceuticals Main Business
Table 81. Curium Pharmaceuticals Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. Curium Pharmaceuticals Latest Developments
Table 83. Jubilant DraxImage Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 84. Jubilant DraxImage Nuclear Drug for Therapeutic Product Offered
Table 85. Jubilant DraxImage Main Business
Table 86. Jubilant DraxImage Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 87. Jubilant DraxImage Latest Developments
Table 88. Lantheus Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 89. Lantheus Nuclear Drug for Therapeutic Product Offered
Table 90. Lantheus Main Business
Table 91. Lantheus Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 92. Lantheus Latest Developments
Table 93. Spectrum Pharmaceuticals Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 94. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
Table 95. Spectrum Pharmaceuticals Main Business
Table 96. Spectrum Pharmaceuticals Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 97. Spectrum Pharmaceuticals Latest Developments
Table 98. Progenics Pharmaceuticals Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 99. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Product Offered
Table 100. Progenics Pharmaceuticals Main Business
Table 101. Progenics Pharmaceuticals Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 102. Progenics Pharmaceuticals Latest Developments
Table 103. International Isotopes Details, Company Type, Nuclear Drug for Therapeutic Area Served and Its Competitors
Table 104. International Isotopes Nuclear Drug for Therapeutic Product Offered
Table 105. International Isotopes Nuclear Drug for Therapeutic Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 106. International Isotopes Main Business
Table 107. International Isotopes Latest Developments
LIST OF FIGURES
Figure 1. Nuclear Drug for Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nuclear Drug for Therapeutic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Nuclear Drug for Therapeutic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Nuclear Drug for Therapeutic Sales Market Share by Country/Region (2022)
Figure 8. Nuclear Drug for Therapeutic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Nuclear Drug for Therapeutic Market Size Market Share by Type in 2022
Figure 10. Nuclear Drug for Therapeutic in Thyroid
Figure 11. Global Nuclear Drug for Therapeutic Market: Thyroid (2018-2023) & ($ Millions)
Figure 12. Nuclear Drug for Therapeutic in Bone Metastasis
Figure 13. Global Nuclear Drug for Therapeutic Market: Bone Metastasis (2018-2023) & ($ Millions)
Figure 14. Nuclear Drug for Therapeutic in Lymphoma
Figure 15. Global Nuclear Drug for Therapeutic Market: Lymphoma (2018-2023) & ($ Millions)
Figure 16. Nuclear Drug for Therapeutic in Other
Figure 17. Global Nuclear Drug for Therapeutic Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Nuclear Drug for Therapeutic Market Size Market Share by Application in 2022
Figure 19. Global Nuclear Drug for Therapeutic Revenue Market Share by Player in 2022
Figure 20. Global Nuclear Drug for Therapeutic Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Nuclear Drug for Therapeutic Market Size 2018-2023 ($ Millions)
Figure 22. APAC Nuclear Drug for Therapeutic Market Size 2018-2023 ($ Millions)
Figure 23. Europe Nuclear Drug for Therapeutic Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Nuclear Drug for Therapeutic Market Size 2018-2023 ($ Millions)
Figure 25. Americas Nuclear Drug for Therapeutic Value Market Share by Country in 2022
Figure 26. United States Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Nuclear Drug for Therapeutic Market Size Market Share by Region in 2022
Figure 31. APAC Nuclear Drug for Therapeutic Market Size Market Share by Type in 2022
Figure 32. APAC Nuclear Drug for Therapeutic Market Size Market Share by Application in 2022
Figure 33. China Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Nuclear Drug for Therapeutic Market Size Market Share by Country in 2022
Figure 40. Europe Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Figure 41. Europe Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Figure 42. Germany Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 56. APAC Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 57. Europe Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 59. United States Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 60. Canada Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 63. China Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 64. Japan Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 65. Korea Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 67. India Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 68. Australia Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 69. Germany Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 70. France Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 71. UK Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 72. Italy Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 73. Russia Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 74. Spain Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 77. Israel Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 80. Global Nuclear Drug for Therapeutic Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Nuclear Drug for Therapeutic Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Nuclear Drug for Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nuclear Drug for Therapeutic Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Nuclear Drug for Therapeutic Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Nuclear Drug for Therapeutic Sales Market Share by Country/Region (2022)
Figure 8. Nuclear Drug for Therapeutic Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Nuclear Drug for Therapeutic Market Size Market Share by Type in 2022
Figure 10. Nuclear Drug for Therapeutic in Thyroid
Figure 11. Global Nuclear Drug for Therapeutic Market: Thyroid (2018-2023) & ($ Millions)
Figure 12. Nuclear Drug for Therapeutic in Bone Metastasis
Figure 13. Global Nuclear Drug for Therapeutic Market: Bone Metastasis (2018-2023) & ($ Millions)
Figure 14. Nuclear Drug for Therapeutic in Lymphoma
Figure 15. Global Nuclear Drug for Therapeutic Market: Lymphoma (2018-2023) & ($ Millions)
Figure 16. Nuclear Drug for Therapeutic in Other
Figure 17. Global Nuclear Drug for Therapeutic Market: Other (2018-2023) & ($ Millions)
Figure 18. Global Nuclear Drug for Therapeutic Market Size Market Share by Application in 2022
Figure 19. Global Nuclear Drug for Therapeutic Revenue Market Share by Player in 2022
Figure 20. Global Nuclear Drug for Therapeutic Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Nuclear Drug for Therapeutic Market Size 2018-2023 ($ Millions)
Figure 22. APAC Nuclear Drug for Therapeutic Market Size 2018-2023 ($ Millions)
Figure 23. Europe Nuclear Drug for Therapeutic Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Nuclear Drug for Therapeutic Market Size 2018-2023 ($ Millions)
Figure 25. Americas Nuclear Drug for Therapeutic Value Market Share by Country in 2022
Figure 26. United States Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Nuclear Drug for Therapeutic Market Size Market Share by Region in 2022
Figure 31. APAC Nuclear Drug for Therapeutic Market Size Market Share by Type in 2022
Figure 32. APAC Nuclear Drug for Therapeutic Market Size Market Share by Application in 2022
Figure 33. China Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Nuclear Drug for Therapeutic Market Size Market Share by Country in 2022
Figure 40. Europe Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Figure 41. Europe Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Figure 42. Germany Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Nuclear Drug for Therapeutic Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Nuclear Drug for Therapeutic Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 56. APAC Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 57. Europe Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 59. United States Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 60. Canada Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 63. China Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 64. Japan Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 65. Korea Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 67. India Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 68. Australia Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 69. Germany Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 70. France Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 71. UK Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 72. Italy Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 73. Russia Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 74. Spain Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 77. Israel Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Nuclear Drug for Therapeutic Market Size 2024-2029 ($ Millions)
Figure 80. Global Nuclear Drug for Therapeutic Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Nuclear Drug for Therapeutic Market Size Market Share Forecast by Application (2024-2029)
